Introduction
Clearly, the use of chemotherapy in these patients as first line therapy may not be in the best interest of the patients, particularly in the era of Page 3 of 21 targeted therapies. Being able to identify these patients prior to using DNA damaging agents would be preferable. One area of interest in CLL research is the role of sub-clonal evolution in the course of this disease. Due largely to the recent advances in sequencing technologies, it is now appreciated that an individual cancer, such as CLL, consists of populations of genetically heterogeneous cells (5) (6) (7) (8) . The cancer itself evolves and develops as a result of not only the interactions between these genetically different sub-clones, but also on the response of each sub-clone to any given treatment.
Chemotherapy intervention may eradicate treatment-sensitive sub-clones, whilst enabling an expansion of the treatment-resistant cell populations (9-11), leading to disease relapse and/or chemo-refractoriness in some patients.
Therefore, there is a pressing clinical need to identify and to better understand the biology of small sub-clonal populations which may contain common chromosomal alterations at diagnosis, as well as monitoring the dynamic changes in these populations during the disease course. This would inform us about the clonal evolution of the disease, and may also guide prognostication. 
Conventional FISH
Conventional FISH was carried out on PBMCs extracted from CLL patients as 
Laser scanning cytometry (LSC)
The slides were prepared for conventional FISH were analyzed on a
CompuCyte iCys™ laser scanning cytometer as follows. Initial low-resolution scan with 405 nm wavelength was performed to determine a suitable region.
Within this region, an area was selected at random for high-resolution 
FISH-IS
The published FISH-IS methods (14, 15) were applied with several modifications (Supplementary Table 1 
Results

FISH-IS is applicable to CLL patient samples
To apply this technique to CLL cells, a model of monosomy was used.
FISH-IS was carried out using the centromere Y probe on male CLL samples 
FISH-IS is able to accurately determine ploidy by fluorescence intensity on autosomes and sex chromosomes
Centromeric probe for chromosome 9 (unaffected by the common genetic aberrations in CLL), chromosome 12 (common trisomy in CLL) and the X chromosome were evaluated using the FISH-IS protocol established above. FISH-IS was able to accurately detect disomy and trisomy in CLL samples using these centromere probes (Supplementary Figure 3 and 4) .
The sensitivity of this detection method was then determined using a known ratio mixture of male and female CLL cells hybridized with an X chromosome probe, allowing discrimination between monosomy (male CLL Table 2 ).
The ability to detect trisomy 12 in CLL was also confirmed using a CLL patient sample previously diagnosed with 95% trisomy 12 by conventional FISH (n=200) was analyzed by FISH-IS. The results for this patient sample were comparable to standard FISH results, identifying 95.1% trisomy 12 and 4.9% disomy 12 (n=20,000) (Supplementary Figure 4) .
Spot count needs manual correction to detect ploidy
The spot count (Spot Wizard or algorithm spot count) was compared with fluorescence intensity as a means of discriminating between monosomic, disomic and trisomic CLL sub-clones. However, in all cases, except for the detection of 100% monosomy with the Y chromosome centromere probe on male samples, the calculated spot count did not accurately estimate the expected signal (Figure 3 ).
Cell-by-cell images visually inspected revealed two limitations in enumerating spots by the spot count software. Firstly, the software was unable to discriminate two juxtaposed spots or partially or completely superimposed spots ( Figure 4D ). This issue can be resolved by observing the overall fluorescence intensity being greater than for a true single spot. The second issue was that spots located outside of the cell were occasionally incorrectly counted by spot count. This can be improved by manually inspecting the "3-spots" gate ( Figure 4E ). Table 3 ).
With high frequency sub-clones, the percentages of trisomy 12 were comparable using the three methods, while greater disparity in the estimated frequency of small sub-clones was evident. FISH-IS showed lower estimates while LSC showed higher estimates compared with conventional FISH ( Figure   5A , B).
Discussion
This study has analyzed the applicability of the high throughput method FISH-IS in accurately identifying monosomy (chromosome Y centromere) and disomy (chromosome 9 centromere) and trisomy (chromosome 12 centromere) in CLL patient samples.
In analyzing the FISH-IS data, it was clear that the overall fluorescence of the cell gave an accurate representation of the hybridization signal, and therefore this method could accurately discriminate between monosomy/disomy and disomy/trisomy. Unfortunately, whilst the current software is able to discriminate between cells with a different number of signals by fluorescence intensity, it is less able to correctly determine the exact number of signals within these cells, using the 'spot count' feature.
There are several aspects of this system which may be causing this. The software records a 2-dimensional image representation of a 3-dimensional object (the cell). Therefore, if spots are at different depths along the same axis as the camera, the conversion to a 2-dimensional image may cause the two spots to be partially or entirely merged. When manually curating the "1-spot" cells, some were easily discernible by eye as being two spots ( Figure 4D ).
However, the software was unable to discriminate them as two distinct spots.
These issues no doubt contribute to the inaccuracy of the current spot count wizard. Previous studies have found a similar level of miscounting spots with the current software (14, 16, 17) . There is a pressing need for further development of this software so that spot counting is an accurate and reproducible analysis step, without requiring manual curation and confirmation which is a significant limitation of this methodology.
Conventional FISH is the current standard method for determining clinically relevant chromosomal abnormalities in CLL, including trisomy 12.
Here we have undertaken a limited comparison between conventional FISH and two high throughput methods, FISH-IS and LSC, using trisomy 12 as our model. Firstly, it is important to recognize that all of these methods rely on the successful and accurate hybridization of a labelled probe to the genetic material within a cell. Therefore, it follows that these methods, whether high- The LSC method is not however without its limitations. Firstly, the LSC machine itself represents expensive and highly specialized equipment; thereby access will be the limiting factor for most researchers or diagnostic centers in applying this method. In terms of the actual method of signal detection, LSC detects cells by the primary contour (visualized as DAPIstained nuclei) and enumerates any hybridized probes by the secondary contour. However, both the hybridized probes and the nuclei can vary greatly in relative fluorescence intensities and size, requiring a large training range of acceptable contours to be established to ensure correct detection of all cells and hybridized probes. The fluorescence signals can also occur at variable depths along the optical axis, which can also lead to incorrect spot counting per cell. Therefore, the accuracy of the spot counting analysis needs to be checked by manually scoring a random sample of the cells, in order to ensure that these factors are not resulting in a flawed automated analysis. In addition, there are several parameters, which need to be established prior to scanning the slides, for example, the focal length of the camera needs to be adjusted according to the thickness of the covering glass and the sample itself.
Considering these factors, the application of LSC in FISH analysis is considered a semi-automated procedure (20, 24) .
By contrast, FISH-IS is able to provide accurate data generated from thousands of cells by analyzing the fluorescence intensity of the samples. al. (2) reported that trisomy 12 is the third most frequent chromosomal aberrations in CLL, found in 16% of all cases, and in isolation, confers an intermediate outcome.
Other studies have since found that trisomy 12 may actually be associated with either a good or a poor prognosis (25, 26) . These conflicting findings may be due to differences in the proportion of CLL cells carrying trisomy 12 and additional mutations present in the sub-clones.
Gonzalez-Gascon et al. found that trisomy 12 had to be present in >60% of CLL cells to confer a poor outcome (27) . Moreover, trisomy 12 often emerges in early stage CLL therefore may act as a driver mutation for secondary genetic alterations (e.g. NOTCH1 and TP53 mutations) (8, 10, 28, 29) .
Therefore, the detection of sub-clones carrying trisomy 12 appears important in the understanding of the biology of the disease eventually resulting in diagnostic and prognostic information which ultimately effects treatment decisions.
It is noteworthy that the signal intensity generated using a centromere probe is vastly different from single allele probes making analysis of important chromosomal aberrations such as del17p and del11q difficult to demonstrate by FISH-IS. The next focus for this analysis is to further modify the highthroughput methodologies to be applicable for smaller intra-chromosomal aberrations commonly found in CLL, such as del11q, del13p, and del17p. This is the subject of our ongoing research. 
